Barbara Carlini

603 total citations
19 papers, 353 citations indexed

About

Barbara Carlini is a scholar working on Neurology, Cancer Research and Molecular Biology. According to data from OpenAlex, Barbara Carlini has authored 19 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 7 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Barbara Carlini's work include Neuroblastoma Research and Treatments (19 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Virus-based gene therapy research (4 papers). Barbara Carlini is often cited by papers focused on Neuroblastoma Research and Treatments (19 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Virus-based gene therapy research (4 papers). Barbara Carlini collaborates with scholars based in Italy, United States and United Kingdom. Barbara Carlini's co-authors include Maria Valeria Corrias, Vito Pistoia, Alberto Garaventa, Fabio Morandi, Michela Croce, Silvano Ferrini, Loredana Amoroso, Raffaella Meazza, Riccardo Haupt and Anna Maria Orengo and has published in prestigious journals such as Clinical Cancer Research, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Barbara Carlini

19 papers receiving 350 citations

Peers

Barbara Carlini
Alex Cazes France
A Zellner Austria
Nai‐Kong V. Cheung United States
N C Cheng Netherlands
Rachel Ingraham United States
Jo Lynne Rokita United States
Quan-Sheng Zhu United States
Barbara Carlini
Citations per year, relative to Barbara Carlini Barbara Carlini (= 1×) peers Kai-Oliver Henrich

Countries citing papers authored by Barbara Carlini

Since Specialization
Citations

This map shows the geographic impact of Barbara Carlini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Carlini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Carlini more than expected).

Fields of papers citing papers by Barbara Carlini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Carlini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Carlini. The network helps show where Barbara Carlini may publish in the future.

Co-authorship network of co-authors of Barbara Carlini

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Carlini. A scholar is included among the top collaborators of Barbara Carlini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Carlini. Barbara Carlini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cangelosi, Davide, Chiara Brignole, Roberto Tamma, et al.. (2022). Nucleolin expression has prognostic value in neuroblastoma patients. EBioMedicine. 85. 104300–104300. 7 indexed citations
2.
Morandi, Fabio, Sarah Pozzi, Sebastiano Barco, et al.. (2016). CD4+CD25hiCD127 Treg and CD4+CD45R0+CD49b+LAG3+ Tr1 cells in bone marrow and peripheral blood samples from children with neuroblastoma. OncoImmunology. 5(12). e1249553–e1249553. 17 indexed citations
3.
Morandi, Fabio, Sarah Pozzi, Barbara Carlini, et al.. (2016). Soluble HLA-G and HLA-E Levels in Bone Marrow Plasma Samples Are Related to Disease Stage in Neuroblastoma Patients. Journal of Immunology Research. 2016. 1–6. 15 indexed citations
4.
Morandi, Fabio, Michela Croce, Giuliana Cangemi, et al.. (2015). IL-10 and ARG-1 Concentrations in Bone Marrow and Peripheral Blood of Metastatic Neuroblastoma Patients Do Not Associate with Clinical Outcome. Journal of Immunology Research. 2015. 1–9. 17 indexed citations
5.
Stigliani, Sara, Michela Croce, Fabio Morandi, et al.. (2015). Expression ofFOXP3,CD14, andARG1in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival. BioMed Research International. 2015. 1–10. 8 indexed citations
6.
Stigliani, Sara, Paola Scaruffi, Corrado Lagazio, et al.. (2015). Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients. Oncotarget. 6(15). 13295–13308. 12 indexed citations
7.
Parodi, Stefano, Marco Muselli, Barbara Carlini, et al.. (2012). Restricted ROC curves are useful tools to evaluate the performance of tumour markers. Statistical Methods in Medical Research. 25(1). 294–314. 5 indexed citations
8.
Morandi, Fabio, Maria Valeria Corrias, Isabella Levreri, et al.. (2011). Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients. Cancer Immunology Immunotherapy. 60(10). 1485–1495. 18 indexed citations
9.
Corrias, Maria Valeria, Riccardo Haupt, Barbara Carlini, et al.. (2011). Multiple target molecular monitoring of bone marrow and peripheral blood samples from patients with localized neuroblastoma and healthy donors. Pediatric Blood & Cancer. 58(1). 43–49. 25 indexed citations
10.
Corrias, Maria Valeria, Angela Pistorio, Giuliana Cangemi, et al.. (2010). Detection of cell‐free RNA in children with neuroblastoma and comparison with that of whole blood cell RNA. Pediatric Blood & Cancer. 54(7). 897–903. 4 indexed citations
11.
Granchi, Donatella, Maria Valeria Corrias, Alberto Garaventa, et al.. (2010). Neuroblastoma and bone metastases: Clinical significance and prognostic value of Dickkopf 1 plasma levels. Bone. 48(1). 152–159. 25 indexed citations
12.
Croce, Michela, Maria Valeria Corrias, Anna Maria Orengo, et al.. (2009). Transient depletion of CD4+ T cells augments IL‐21‐based immunotherapy of disseminated neuroblastoma in syngeneic mice. International Journal of Cancer. 127(5). 1141–1150. 20 indexed citations
13.
Corrias, Maria Valeria, Stefano Parodi, Riccardo Haupt, et al.. (2008). Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma. British Journal of Cancer. 98(2). 263–269. 17 indexed citations
14.
Croce, Michela, Raffaella Meazza, Anna Maria Orengo, et al.. (2008). Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen. Cancer Immunology Immunotherapy. 57(11). 1625–1634. 28 indexed citations
15.
Ribatti, Doménico, B Nico, Annalisa Pezzolo, et al.. (2006). Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-γ. British Journal of Cancer. 94(12). 1845–1852. 37 indexed citations
16.
Rosanda, Cristina, Claudio Gambini, Barbara Carlini, et al.. (2006). Diagnostic identification of malignant cells in the cerebrospinal fluid by tumor-specific qRT-PCR. Clinical & Experimental Metastasis. 23(3-4). 223–226. 2 indexed citations
17.
Corrias, Maria Valeria, Riccardo Haupt, Barbara Carlini, et al.. (2006). Peripheral Blood Stem Cell Tumor Cell Contamination and Survival of Neuroblastoma Patients. Clinical Cancer Research. 12(19). 5680–5685. 28 indexed citations
18.
Airoldi, Irma, Lizzia Raffaghello, Erich Piovan, et al.. (2006). CXCL12 Does Not Attract CXCR4+ Human Metastatic Neuroblastoma Cells: Clinical Implications. Clinical Cancer Research. 12(1). 77–82. 41 indexed citations
19.
Croce, Michela, Raffaella Meazza, Anna Maria Orengo, et al.. (2005). Sequential Immunogene Therapy with Interleukin-12– and Interleukin-15–Engineered Neuroblastoma Cells Cures Metastatic Disease in Syngeneic Mice. Clinical Cancer Research. 11(2). 735–742. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026